These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alpha 1A-adrenoceptor-mediated contractile responses of the human vas deferens. Furukawa K; Rosario DJ; Smith DJ; Chapple CR; Uchiyama T; Chess-Williams R Br J Pharmacol; 1995 Sep; 116(1):1605-10. PubMed ID: 8564226 [TBL] [Abstract][Full Text] [Related]
23. Quantitative relationship between alpha 1-adrenergic receptor density and the receptor-mediated calcium response in individual astroglial cells. Shao Y; McCarthy KD Mol Pharmacol; 1993 Aug; 44(2):247-54. PubMed ID: 8102780 [TBL] [Abstract][Full Text] [Related]
24. Two phases of contractile response in rat isolated vas deferens and their regulation by adenosine and alpha-receptors. Major TC; Weishaar RE; Taylor DG Eur J Pharmacol; 1989 Aug; 167(3):323-31. PubMed ID: 2572433 [TBL] [Abstract][Full Text] [Related]
25. Region and age dependent differences in alpha(1)-adrenergic responsiveness of rat seminal vesicle and vas deferens. Yono M; Latifpour J; Yamamoto Y; Imanishi A; Yoshida M Eur J Pharmacol; 2008 Jun; 587(1-3):291-5. PubMed ID: 18472093 [TBL] [Abstract][Full Text] [Related]
26. Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen. Teng CM; Guh JH; Ko FN Eur J Pharmacol; 1994 Nov; 265(1-2):61-6. PubMed ID: 7883030 [TBL] [Abstract][Full Text] [Related]
27. Postsynaptic alpha 1-adrenoceptor mechanisms in rat vas deferens and ageing. Takayanagi I; Maeda O; Koike K J Pharm Pharmacol; 1987 Sep; 39(9):754-7. PubMed ID: 2890748 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of presynaptic alpha-2-adrenoceptor and opioid receptor agonist responses in the rat vas deferens by chronic imipramine treatment. Keith RA; Salama AI Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):412-9. PubMed ID: 2885761 [TBL] [Abstract][Full Text] [Related]
29. Contractile actions of imidazoline alpha-adrenoceptor agonists and effects of noncompetitive alpha1-adrenoceptor antagonists in human vas deferens. Amobi N; Guillebaud J; Kaisary A; Lloyd-Davies RW; Turner E; Smith IC Eur J Pharmacol; 2003 Feb; 462(1-3):169-77. PubMed ID: 12591110 [TBL] [Abstract][Full Text] [Related]
30. The effect of age on the sensitivity of pre- and postsynaptic alpha-adrenoceptors to agonists and antagonists in the rat. McAdams RP; Waterfall JF Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):430-5. PubMed ID: 2881219 [TBL] [Abstract][Full Text] [Related]
31. The vas deferens as a suitable preparation for the study of alpha-adrenoreceptor molecular mechanisms. Cordellini S; Sannomiya P J Pharmacol Methods; 1984 Apr; 11(2):97-107. PubMed ID: 6325822 [TBL] [Abstract][Full Text] [Related]
32. [Action of dihydroergocristine at pre- and postsynaptic alpha-adrenoceptors in the rat isolated vas deferens]. Roquebert J; Demichel P; Gomond P; Malek A J Pharmacol; 1983; 14(2):151-9. PubMed ID: 6134866 [TBL] [Abstract][Full Text] [Related]
33. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053. Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428 [TBL] [Abstract][Full Text] [Related]
34. Interaction between 2-chloroadenosine and alpha-adrenoceptors in rat vas deferens. Lai RT; Watanabe Y; Kamino Y; Yoshida H Life Sci; 1984 Jan; 34(5):409-18. PubMed ID: 6319943 [TBL] [Abstract][Full Text] [Related]
35. Alpha 2-adrenoceptor-mediated responses to so-called selective alpha 1-adrenoceptor agonists after partial blockade of alpha 1-adrenoceptors. Guimarães S; Paiva MQ; Moura D Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):397-402. PubMed ID: 2885759 [TBL] [Abstract][Full Text] [Related]
36. The recovery of alpha-adrenoceptor function and binding sites after phenoxybenzamine. An index of receptor turnover? Hamilton CA; Dalrymple HW; Reid JL; Sumner DJ Naunyn Schmiedebergs Arch Pharmacol; 1984 Jan; 325(1):34-41. PubMed ID: 6324006 [TBL] [Abstract][Full Text] [Related]
37. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Doxey JC; Roach AG; Smith CF Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640 [TBL] [Abstract][Full Text] [Related]
38. Effects of St-587 on the alpha-adrenoceptors in the bisected rat vas deferens. Badia A; Sallés J J Pharm Pharmacol; 1989 Sep; 41(9):612-6. PubMed ID: 2573705 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the alpha 1-adrenoceptor subtype mediating contraction of guinea-pig spleen. Eltze M Eur J Pharmacol; 1994 Aug; 260(2-3):211-20. PubMed ID: 7988645 [TBL] [Abstract][Full Text] [Related]
40. Activation of alpha 1-adrenoceptors increases [3H]inositol metabolism in rat vas deferens and caudal artery. Fox AW; Abel PW; Minneman KP Eur J Pharmacol; 1985 Oct; 116(1-2):145-52. PubMed ID: 2865157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]